← Back
$LXRX All transactions

LEXICON PHARMACEUTICALS, INC.

▲ BUY
5 / 10

Conviction

$ Value

$3K

Shares

2,000

Price

$1

Filed

Feb 27

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

DEBBANE RAYMOND

Title

CIK

0001053890

Roles

Director

Transaction Details

Transaction Date

2026-02-25

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,906,186

Filing Info

Accession No.

0001062822-26-000033

Form Type

4

Issuer CIK

0001062822

DEBBANE RAYMOND's History

Date Ticker Type Value
2026-02-25 LXRX $3K
2026-02-23 LXRX $147K
2026-02-20 LXRX $148K
2026-02-19 LXRX $72K
2026-02-18 LXRX $176K
2026-02-17 LXRX $101K
2026-02-13 LXRX $76K
2025-06-03 LXRX A $0
2025-06-03 LXRX A $0
2025-05-13 LXRX M $0

Other Insiders at LXRX (90d)

Insider Bought Sold Last
Invus Global Management, LLC $2.0M 2026-02-02
DEBBANE RAYMOND $720K 2026-02-23
Coiante Scott M
SVP, Chief Financial Officer
2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
2026-02-28
DeFrancesco Lisa
SVP, IR and Corp Comm
2026-02-28
Granowitz Craig B
SVP, Chief Medical Officer
2026-02-28
McDermott Wendy
SVP, Human Resources
2026-02-28
Exton Michael
Chief Executive Officer
2026-02-28
Artal Participations S.a r.l. 2026-02-17
Gopinathan Suma
SVP, Discovery
2026-02-28
Martens Rachel Yap
SVP, Partnerships & Corp Strat
2026-02-28